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ABSTRACT 
Rationale The effects of caffeine on mood and performance are well established. 
Some authors suggest that caffeine merely reverses effects of caffeine withdrawal 
rather than having direct behavioural effects. It has also been suggested that 
withdrawal may be removed by a first dose of caffeine and further doses have little 
subsequent effect. These issues were examined here.  
Objectives The present study aimed to determine whether caffeine withdrawal 
influenced mood and performance by comparing regular consumers who had been 
withdrawn from caffeine overnight with non-consumers. Following this repeated 
caffeine doses were administered to test the claim that repeated dosing has no extra 
effect on mood or performance. Secondary analyses of a data collected by Christopher 
et al. (2003) were also carried out to examine some alternative explanations of their 
results which showed effects of caffeine after a day of normal caffeine consumption. 
Methods  One hundred and twenty volunteers participated in the study. Regular 
caffeine consumption was assessed by questionnaire and this showed that thirty six of 
the sample did not regularly consume caffeinated beve rages. Volunteers were 
instructed to abstain from caffeine overnight and then completed a baseline session 
measuring mood and a range of cognitive functions at 08.00 the next day. Following 
this volunteers were given 0, or 1mg/kg caffeine in a milkshake, glucose solution or 
water (at 09:00), followed by a second 0 or 1mg/kg caffeine dose (at 09:40) and the 
test battery repeated at 10:00. 
Results The baseline data showed no effect of overnight caffeine withdrawal on mood 
or performance. In contrast, caffeine challenge improved vigilance performance and 
prevented decreases in alertness induced by completion of the task battery. The 
magnitude of these effects increased as a function of the number of doses of caffeine 
given. Secondary analyses of data from Christopher et al. (2003) also confirmed that 
effects of caffeine did not depend on length of withdrawal. 
Conclusions  The present findings show no effect of overnight caffeine withdrawal on 
mood and performance. Caffeine challenge did have the predicted effect on alertness 
and vigilance, with the size of the effects increasing with caffeine dose. These 
findings suggest that the effects of caffeine are not due to reversal of effects of 
withdrawal, a view confirmed by secondary analyses of data collected after a day of 
normal caffe ine consumption. 
KEY WORDS - Caffeine; caffeine withdrawal; alertness; cognitive performance 
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INTRODUCTION 
 
It has been suggested that the behavioural effects of caffeine can be attributed to 
reversal of effects of caffeine withdrawal (James and Rogers, 2005). Many studies 
that have interpreted effects of caffeine in terms of reversal of caffeine withdrawal 
have not actually demonstrated effects of caffeine withdrawal and effects of caffeine 
in the same study (e.g. Durlach et al., 2002; Smit and Rogers, 2000; Yeomans et al., 
2002). This issue has been examined by comparing withdrawn consumers with non-
consumers of caffeine and recent research using this approach has largely failed to 
demonstrate negative effects of caffeine withdrawal (Haskell et al., 2005; Hewlett and 
Smith, 2006a; Smith et al., 2005). The present study also used this methodology to 
determine whether effects of caffeine withdrawal could be observed. 
One type of evidence put forward to support the withdrawal hypothesis is the 
finding that repeated doses of caffeine (testing while non-withdrawn or following 
caffeine pre- load) do not produce greater effects than the initial dose (Robelin and 
Rogers, 1998; Yeomans et al., 2002). Smith et al. (2003) have suggested that caffeine 
produces different types of effect depending on type of task (processing required) and 
arousal level of the volunteer. This is consistent with results showing that caffeine 
influences many different neurotransmitter systems (Fredholm et al., 1999). Caffeine 
improves performance of tasks involving sustained encoding of new information (e.g. 
the repeated digits cognitive vigilance task, Smith et al., 2003) even when the 
alertness level of the person is high. In contrast, the effects of caffeine on lapses of 
attention and improved performance on simple reaction time tasks are most easily 
observed when alertness is low. Other tasks, such as those involving episodic 
memory, are rarely affected by caffeine (see Smith, 2005). It is important, therefore, 
to consider the impact of caffeine withdrawal and subsequent caffeine challenge on all 
of these different tasks and this has rarely been attempted in previous studies. The 
present study had this methodological feature and examined effects of repeated doses 
of caffeine in alert individuals. It was predicted that caffeine would improve 
performance on the repeated digits vigilance task but have little effect on memory 
tasks or tasks that are largely improved by caffeine when alertness is reduced (simple 
reaction time and lapses of attention in choice reaction time tasks). 
Previous studies of effects of repeated doses of caffeine often have deficiencies in 
design, analysis  and interpretation. Yeomans et al. (2002) used a cross-over design 
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and showed that order of caffeine treatments had a significant effect, with those who 
had caffeine first showing better performance. Given this effect of order, the analyses 
should have been restricted to the first run data, which, at least numerically, would 
have shown that a second dose of caffeine improves cognitive vigilance. Robelin and 
Rogers (1998) found that caffeine had no effect on performance of a simple reaction 
time task in the morning but reduced the post- lunch dip in performance seen in those 
given placebo. This can be interpreted as caffeine only having an effect on this task 
when alertness is reduced and that this effect occurs whether or not the person has had 
one or more caffeinated drinks. Heatherley et al. (2005) found that a second dose of 
caffeine only affected cognitive performance and mood after an 8-hour interval 
between doses. This is interpreted in terms of withdrawal effects only becoming 
apparent after 8-hours although no data are shown to indicate whether length of 
caffeine withdrawal influenced pre-challenge performance. If the groups did not differ 
pre-challenge it would not be possible to interpret the results in terms of withdrawal. 
Indeed, it may be the case that those in the 8-hour deprivation group were more 
fatigued prior to the second drink  (due to factors other than withdrawal, e.g. having to 
get up earlier) and an effect in this group would then be consistent with caffeine 
having a larger effect in low alertness groups. 
Other research has examined effects of caffeine after a day of normal consumption. 
James and Rogers (2005) have criticised these studies for failing to supervise 
consumption. Indeed, they suggest that the effects of caffeine reported by Christopher 
et al. (2005) could be due to a sub-group of participants who abstained from caffeine 
for > 6 hours. This issue is considered in a series of secondary analyses in the second 
section of this paper. Smith et al. (2005) examined effects of repeated doses of 
caffeine following a day of normal consumption. They tested volunteers when they 
were alert and fatigued, and were able to show effects of caffeine on both cognitive 
vigilance tasks and those measures that are sensitive to effects of caffeine when the 
person is fatigued (simple reaction time and lapses of attention in choice reaction time 
tasks). These effects were found to increase with repeated doses. 
The aims of the present study were to examine possible effects of caffeine 
withdrawal by comparing non-consumers with withdrawn consumers. Following this 
the study examined effects of repeated doses of caffeine to determine whether effects 
were restricted to the first dose (Yeomans et al., 2002) or whether a subsequent dose 
led to greater effects. A range of tasks were used and it was predicted that the 
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repeated digits task would be improved by caffeine whereas simple reaction time, 
lapses of attention and episodic memory tasks would show no effect. Following this 
study secondary analyses of the data from Christopher et al. (2005) were conducted to 
determine whether length of caffeine withdrawal influenced the effects of caffeine. 
 
 
MATERIALS AND METHODS 
Design 
A between subjects design was used with three factors: regular caffeine consumption 
dose of caffeine, and nature of  the breakfast condition (see below), which determined 
the vehicle in which the caffeine was given.  Regular caffeine consumers and non-
consumers were randomly assigned to one of four conditions representing the 
presence or absence of caffeine in two drinks: 
  Drink 1  Drink 2 
Condition 1: Caffeine  Caffeine  (two doses of caffeine) 
Condition 2: Caffeine  No caffeine   (one dose of caffeine) 
Condition 3:    No caffeine  Caffeine   (one dose of caffeine) 
Condition 4:    No caffeine  No caffeine   (no caffeine) 
 
Sample size 
Studies of the effects of caffeine in alert individuals typically show an effect size of 
0.8 SD so at least 24 participants were required per condition. The sample was larger 
because the caffeine manipulation was part of a larger study involving carbohydrate 
manipulations. 
  
Participants 
120 participants (66% female) took part in the study and these were recruited from 
the population of students of Cardiff University. Participants were divided into high, 
low and non-consumers on the basis of levels of regular caffeine consumption. 
Consumption data was missing for 7 participants and analyses involving this factor 
were based on an N of 113. Mean (s.d.) caffeine consumption was 212.0 (136.8) 
mg/day for the higher consumers (over 100mg/day), 53.6 (24.4) mg/ day for the lower 
consumers (100mg/day or less) and 0.0 mg/day for the non-consumers. Participants 
were screened for medical conditions/medications. Smokers were excluded to avoid 
any effects of tobacco or tobacco withdrawal. People with scores of over 55 on the 
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Spielberger Trait Anxiety Inventory were excluded. Details of the sample, sub-
divided by regular consumption, can be seen in Table 1. 
Insert Table 1 about here 
 
Procedure 
Before the testing day, volunteers were familiarised with the procedure and the test 
battery. All volunteers were made aware of the nature of the testing and the drinks 
(water, glucose or milkshake) that would be consumed. Written informed consent was 
obtained. On the testing day, participants arrived at the unit at 08:00 and carried out  
their baseline tests having had no breakfast and having had no caffeine or alcohol for 
at least seven hours and having done no strenuous exercise. This was followed by the 
appropriate drink type (approx 08:55). They then received the second drink  (water) at 
09:45 followed by the second test battery at 10:00. The session finished at 
approximately 10:55. Participants were allowed to drink water freely, but were asked 
to refrain from any other food or drinks during the testing period. Participants were 
paid £20. 
Nature of breakfasts 
Volunteers were randomly assigned to five breakfast conditions which are described 
in detail in Hewlett (2005): 
1. Glucose drink  
2. Glucose milk-shake  
3. Water  
4. Toast (and a drink of water) 
5. Sucrose milk-shake 
The caffeine was given in these 330 ml drinks.  
 
Dose of Caffeine 
The caffeine dose was 1mg/kg body weight. 
 
MOOD AND PERFORMANCE TESTS 
The mood and performance test battery (described in detail in Smith et al., 1999) was 
run on IBM-compatible computers. A response box attached to the computers 
contained a microchip, which controlled timing of the presentation of stimuli and 
timed the responses to the nearest millisecond. 
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The following tasks were chosen as they had previously been used to examine the 
effects of caffeine. Predictions could therefore be made about the effect of caffeine on 
these tasks.  
Mood 
Mood was assessed before and after each battery of tasks using visual analogue rating 
scales (described in detail in Smith et al., 1999). These have been factor analysed to 
produce 3 factors: Alertness, Hedonic tone and Anxiety. 
Performance Tests (in the order completed) 
Free recall (described in detail in Smith et al., 1999) 
A list of 20 words was presented on the screen at a rate of one every 2 seconds. At the 
end of the list volunteers were required to write down as many as possible, in any 
order, within 2 minutes. Volunteers saw a different list at each test session. The 
variables analysed were: the number of words correctly recalled and the number of 
commission errors (words written down that were not in the presented list). 
Focused attention choice reaction time task (Broadbent et al., 1986)   
Target letters appeared as upper case A’s and B’s. On each trial three warning crosses 
appeared on the screen, the outside crosses being separated from the middle one by 
1.02 or 2.60 degrees. Volunteers were required to respond to the target presented in 
the middle of the screen and ignore any distracters presented in the periphery. The 
crosses were on the screen for 500ms before being replaced by the target letter. The 
target letter was either accompanied by nothing, asterisks, letters that were the same 
as the target or letters that differed from the target. The two distracters were identical 
and the targets and the accompanying the letters were always A or B. The correct 
response to “A” was to press the A key with the forefinger of the left hand and the 
correct response to “B” was to press the B key with the forefinger of the right hand. 
Volunteers had 10 practice trials followed by five blocks of 64 trials. In each block 
there were equal numbers of near/far conditions, A or B responses and equal number 
of the four-distracter conditions. The nature of the previous trial was controlled. The 
scores derived from this task were:  
· Mean reaction time. 
· The speed of encoding of new information. This is a derived score taken as the 
difference in reaction time of response between conditions when the target is 
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alternated from the previous trial and when the target is repeated from the 
previous trial. 
· The number of long responses (>800ms). 
· Number of errors. 
Categoric search choice reaction time task (Broadbent et al., 1986)  
Each trial started with the appearance of two crosses in the positions occupied by the 
non-targets in the focused attention task (i.e. 2.04 or 5.20 degrees apart). Volunteers 
did not know which of the crosses the target would follow. The letter A or B was 
presented alone in half the trials and was accompanied by a digit (1-7) in the other 
half. The number of near/far stimuli, A verses B responses and digit/blank conditions 
was controlled. Half the trials led to compatible responses (i.e. the letter A on the left 
side of the screen or letter B on the right) and the other half were incompatible. The 
nature of the previous trial was also controlled. In respect to practice, number of trials 
etc., this task was identical to the focused attention. The variables measured were: 
· Mean reaction time. 
· The speed of encoding of new information. This is a derived score taken as the 
difference in reaction time of response between conditions when the target is 
alternated from the previous trial and when the target is repeated from the 
previous trial. 
· The number of long responses (>1000ms). 
· Number of errors. 
Variable fore-period simple reaction time (described in detail in Smith et al., 1999) 
A square was displayed on the screen and at varying intervals (between 1 and 8 
seconds) a small filled white square appeared in the centre of the larger square. 
Volunteers were required to press a response key as soon as they detected the small 
square. The task lasted for 5 minutes. 
Verbal reasoning (Baddeley, 1968)  
Volunteers were shown a statement such as “A follows B: BA” and they had to decide 
whether the statement was a true description of the order of the letters and press the 
appropriate response key.  Sentences ranged in syntactic complexity from simple 
active to passive negative (e.g. A is not followed by B). The task lasted for 5 minutes. 
The variables measured on this task were: 
· Speed of performance - the number of trials completed within the 5 minutes. 
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· The percentage of correct responses. 
Repeated digit detection task (described in detail in Smith et al., 1999) 
Volunteers were shown three digit numbers on the screen at a rate of 100 per minute. 
Each number differed from the preceding one by one digit. Occasionally (8 
times/minute) the same number was presented twice in succession. Volunteers had to 
detect these repetitions as quickly as possible. The task lasted for 5 minutes. Variables 
recorded were: 
· Number of hits (correct detection of targets). 
· Mean reaction time for hits. 
· Number of false alarms (a response when no target was presented). 
Because the literature sometimes shows an effect of caffeine on hit rate and 
sometimes RT, the RT and hit scores were combined to form a general efficiency 
score (hits /RT). This provides a measure whereby better performance (higher hit rate 
or faster RT) gives a higher score.  
Semantic Memory (Baddeley, 1981) 
This was a sentence verification task in which a series of sentences (e.g. “Crocodiles 
attend religious services”) were presented. Participants were required to indicate as 
quickly as possible whether the statements presented were true or false. The variables 
measured were: 
· The number of trials completed in the 5 minutes. 
· The percentage of correct responses. 
Delayed recognition memory (described in detail in Smith et al., 1999) 
At the end of the testing session volunteers were shown a list of 40 words that 
included the 20 shown at the beginning of the testing session and 20 new distracters. 
Volunteers had to decide as quickly as possible which words were in the original list 
of twenty. The lists differed at each session. The variables measured were: 
· Mean reaction time for the different response categories (hits, correct 
rejections, false alarms and misses). 
· Number of correct responses (i.e. correctly accepting target words and 
correctly rejecting distracter words). 
· The number of false alarms (i.e. wrongly accepting a distracter as being in the 
original list). 
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RESULTS 
Excluded participants and missing data 
Nine volunteers performed at chance level on the logical reasoning test and their data 
were excluded from the analyses of that task. Four volunteers were also excluded 
from the analysis of the semantic memory task because of their poor performance. 
There were missing data for 9 volunteers in the free recall task. 
Withdrawal effects 
Initial analyses were carried out on the baseline data to determine whether regular 
consumers who had abstained from consuming caffeine differed from non-consumers. 
These results are shown in Table 2. The only significant difference between the 
consumer groups was found in the simple reaction time task (F (2,112) = 3.0, p<0.05) 
where the reaction time of the lower consumers was faster than that of the higher 
consumers (p<0.05) and non-consumers (p<0.05). 
Insert Table 2 about here 
 
Post-drink effects 
Table 3 shows the characteristics of the participants in the three different dose 
conditions. There were no significant differences between the dose conditions for 
these variables. 
Analyses of covariance were carried out with the pre-drink measures as the covariate. 
The independent variables were type of breakfast (vehicle in which caffeine given) 
and dose of caffeine. The mood and performance measures from the second session 
were the dependent variables 
Effects of breakfast 
The effects of the type of breakfast on these tests are described in detail elsewhere 
(Hewlett, 2005) and can be briefly summarised as follows.  Breakfast altered pre-
session alertness, with those in the toast condition reporting highest alertness (F 
(4,119) = 3.6, p<0.01). Breakfast also had a significant effect on speed of encoding in 
the categoric search task (F (4,119) = 3.5, p=0.01). Those in the water condition were 
slower to encode new information than those in the toast and glucose milkshake 
conditions (both p’s<0.05).  
There were no significant interactions between the caffeine and breakfast conditions 
showing that any effects of caffeine did not vary as a function of the drink in which it 
was given. 
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Effects of repeated doses of caffeine on alertness 
As expected, post-task alertness was lower than pre-task (F (1,119) = 30.6, p<0.001). 
Mean pre-task alertness was 240.3 (s.e. 4.2) and post-task it was 218.4 (s.e. 5.2). 
There was no difference between caffeine conditions pre-task (p>0.05). There was a 
statistically significant effect of caffeine on post-task alertness (F (2,119) = 8.9, 
p<0.001) where alertness was related to the number of caffeine doses. It can be seen 
in Figure 1 that the more caffeine consumed, the higher the alertness. Planned 
comparisons showed that alertness was approximately 14% higher in the one dose 
than no dose condition (p<0.01), 26% higher in the two dose than no dose condition 
(p<0.001) and 11% higher in the two dose than one dose condition (p<0.05 - see 
Figure 1). 
 
Insert Figure 1 about here 
 
Effects of repeated doses of caffeine on performance 
There was a statistically significant effect of caffeine on performance of the vigilance 
task (F (2,119) = 9.4, p<0.001). Planned comparisons showed that performance 
scores were approximately 12% higher in the one dose than no dose condition 
(p<0.005), 19% higher in the two doses than no dose condition (p<0.001) and 6% 
higher in the two doses than one dose condition (see Figure 2). 
Insert Figure 2 about here 
None of the other tasks showed significant effects of caffeine (see Table 4). 
Insert Table 4 about here 
Caffeine dose and level of regular consumption 
These analyses included dose of caffeine and regular caffeine consumption as 
independent variables. There was only one significant interaction between these 
variables (speed of encoding of new information, categoric search task – see Table 5) 
showing that the effects of different doses of caffeine were consistent across different 
consumer groups. 
 
DISCUSSION 
According to the withdrawal hypothesis, caffeine restores mood and performance 
degraded by the prior withdrawal of caffeine. The present results show similar scores 
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for regular consumers after overnight withdrawal and non-consumers. James and 
Rogers (2005) suggest that non-consumers are a self-selected minority who may be 
atypically sensitive to caffeine or differ from consumers in other ways. In contrast to 
this view, Hewlett and Smith (2006b) found that the major difference between non-
consumers and regular consumers was that non-consumers disliked the beverage in 
which caffeine was normally given. Smith et al. (2005) found no differences between 
consumers and non-consumers in terms of speed of metabolism of caffeine. 
Some studies of the effects of repeated caffeine doses have reported an effect of the 
first caffeine dose but not an effect of a second and this has been taken as evidence for 
the withdrawal hypothesis. These studies can be criticised for assuming the presence 
of withdrawal effects in order to explain the findings. The present study removes the 
possible interpretation of reversal of withdrawal by demonstrating no withdrawal 
effect to reverse. James and Rogers (2005) were also critical of studies that allowed 
participants to provide their own caffeine pre- load. The present study controlled this 
in the laboratory. The suggestion that a pre- load may not remove withdrawal equally 
was shown not to be relevant as baseline comparisons showed no negative effect of 
caffeine withdrawal. Any effects of caffeine subsequently found must be explained 
some other way. 
As expected, pre-task mood was unaffected in the present experiment. This is 
important as it is consistent with the idea that caffeine increases alertness when 
arousal is low and is consistent with other studies showing no effect of caffeine on 
alertness when arousal is high (see Lieberman, 1992). Also as predicted, caffeine 
challenge did increase alertness measured after performing the tasks. This supports 
other results showing beneficial effects of caffeine on alertness in low alertness 
situations (e.g. Smith et al, 1999; Lorist et al, 1994). Furthermore, this study showed 
that a second dose of caffeine produced a greater increase in alertness than a single 
dose. This was also observed for performance of the repeated digits vigilance task. 
Other tasks showed no effect of caffeine and this is consistent with the literature on 
caffeine in general (e.g. absence of effects on episodic memory tasks) or effects of 
caffeine in alert individuals (absence of effects of caffeine on simple reaction time of 
alert volunteers).Effects of caffeine on the speed of encoding have been found in alert 
participants (Smith et al., 2003) and while the numerical trend was in the predicted 
direction, the effect was not significant  in the present study. This could possibly 
reflect the nature of the drink masking the effect of caffeine. 
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The next section of the paper considers effects of caffeine following a day of normal 
consumption. A secondary analysis of data from Christopher et al. (2005) is 
presented to resolve some issues raised in a review of this study (James and Rogers, 
2005). 
 
 
Secondary analysis of Christopher et al. (2005) 
Christopher et al. (2005) and Smith et al. (2005) have shown that caffeine can 
improve mood and performance in individuals who have been allowed to consume 
caffeinated beverages during the day prior to evening testing. In the early evening, 
caffeine was associated with greater alertness, faster speed of encoding of new 
information and better vigilance performance. As volunteers became fatigued during 
the evening (due to declining circadian alertness and prolonged task performance), 
simple reaction time was improved by caffeine and the number of long responses 
reduced by caffeine. These effects of caffeine increased with dose. 
James and Rogers (2005) have criticised the Christopher et al. study because caffeine 
levels in saliva were high at the start of the day. This probably reflects the acute 
effects of caffeine ingestion on saliva levels (Walther et al., 1983) as the volunteers 
may not have rinsed their mouths prior to providing the sample (a procedure that was 
applied when samples were collected in the laboratory later in the day). James and 
Rogers also suggested that the effects obtained by Christopher et al. may have been 
due to a small proportion of volunteers  ( > 6 hours deprivation) responding to 
caffeine with improved mood and performance, with the remainder ( < 6 hours 
deprived) showing no effects. This was examined in the following set of secondary 
analyses. 
Results 
Fifteen (7 in the caffeine condition, 8 in the placebo condition) of the 68 volunteers 
did not consume any caffeinated beverages for more than six hours before the evening 
tests. Analyses of covariance were carried out distinguishing those who had not 
consumed caffeine for > 6 hours before testing and those who had consumed caffeine 
< 6 hours before testing. The results (see Table 6) showed that caffeine improved 
alertness and reduced reaction times in the repeated digits vigilance task for both 
groups ( > 6 hours and < 6 hours withdrawal).  
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Insert Table 6 about here 
CONCLUSION 
In conclusion, the present study was unable to demonstrate differences in mood and 
performance between withdrawn consumers and non-consumers of caffeine. Caffeine 
challenge produced the predicted profile of behavioural changes and these effects 
increased with caffeine dose. Secondary analyses of data from a study of effects of 
caffeine following a day of normal consumption showed that caffeine had similar 
effects in those who had abstained from caffeine for > 6 hours and those who had 
consumed caffeine up to the time of testing. Overall, these results provide little 
support for the view that the behavioural effects of caffeine reflect the reversal of 
effects of caffeine withdrawal. Alternative explanations must be considered (see 
Smith, 2005) and these must be able to account for the task specificity of the effects 
of caffeine and the fact that effects will vary depending on the alertness level of the 
person. 
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Table 1. Age and personality scores of the different consumer groups (means and 
s.e.s) 
 
Consumer 
status Age Imp TA 
Non 
(n=36) 
22.8 (0.7) 4.4 (0.3) 39.5 (1.3) 
Lower 
(n=39) 21.5 (0.7) 4.6 (0.3) 39.0 (1.3) 
Higher 
(n=38) 21.2 (0.7) 4.2 (0.3) 39.5 (1.2) 
TA = trait anxiety.  Imp = impulsivity
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Table 2. Mean (s.e.) baseline scores in the different consumer groups. 
 
Variable Consumer status (n) Mean (s.e.) Consumer group effect 
Non (38) 220.7 (9.7) 
Lower (39) 214.9 (9.3) 
Pre-session alertness 
(high scores=greater 
alertness) Higher  (36) 203.3 (9.5) 
F (2,112)=0.9, 
p>0.05 
Non (38) 187.0 (6.4) 
Lower (39) 181.1 (6.1) 
Pre-session Hedonic 
tone 
(high scores=more 
positive mood) Higher  (36) 
181.3 (6.2) 
F (2,112)=0.3, 
p>0.05 
Non (38) 93.7 (2.9) 
Lower (39) 88.4 (2.7) 
Pre-session anxiety 
(high scores=greater 
calm) Higher  (36) 86.9 (2.8) 
F (2,112)=1.7, 
p>0.05 
Non (38) 189.9 (8.7) 
Lower (39) 180.1 (8.6) 
Post-session alertness 
(high scores=greater 
alertness) Higher  (36) 195.0 (8.4) 
F (2,112)=0.7, 
p>0.05 
Non (38) 172.3 (6.2) 
Lower (39) 164.0 (6.0) 
Post-session Hedonic 
tone 
(high scores=more 
positive mood) Higher  (36) 
166.9 (6.1) 
F (2,112)=0.5, 
p>0.05 
Non (38) 90.5 (2.5) 
Lower (39) 88.1 (2.4) 
Post-session anxiety 
(high scores=greater 
calm) Higher  (36) 86.2 (2.4) 
F (2,112)=0.8, 
p>0.05 
Non (34) 10.6 (0.6) 
Lower (38) 10.6 (0.6) 
Free recall: 
Number recalled 
Higher  (35) 10.6 (0.6) 
F (2,106)=0.1, 
p>0.05 
Non (38) 0.3 (0.2) 
Lower (39) 0.5 (0.1) 
Free recall: 
Commission errors 
Higher  (36) 0.7 (0.2) 
F (2,106)=1.7, 
p>0.05 
Non (38) 383.2 (8.6) 
Lower (39) 384.4 (8.2) 
Focused attention 
Mean RT (ms) 
Higher  (36) 372.3 (8.3) 
F (2,112)=0.6, 
p>0.05 
Non (38) 22.7 (3.6) 
Lower (39) 21.2 (3.5) 
Focused attention 
Speed of encoding 
(ms) Higher  (36) 24.4 (3.5) 
F (2,112)=0.2, 
p>0.05 
Non (38) 1.2 (0.4) 
Lower (39) 0.9 (0.4) 
Focused attention 
Long responses 
Higher  (36) 1.6 (0.4) 
F (2,112)=0.6, 
p>0.05 
Non (38) 14.6 (1.7) 
Lower (39) 12.1 (1.7) 
Focused attention 
Errors 
Higher  (36) 12.6 (1.7) 
F (2,112)=0.6, 
p>0.05 
Non (38) 484.7 (10.2) 
Lower (39) 484.4 (9.8) 
Categoric search 
Mean RT (ms) 
Higher  (36) 476.2 (10.0) 
F (2,112)=0.2, 
p>0.05 
Non (38) 13.2 (3.5) 
Lower (39) 17.6 (3.3) 
Categoric search 
Speed of encoding 
(ms) Higher  (36) 17.2 (3.4) 
F (2,112)=0.5, 
p>0.05 
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Non (38) 12.2 (2.0) 
Lower (39) 11.4 (1.9) 
Categoric search 
Long responses 
Higher  (36) 14.2 (1.9) 
F (2,112)=0.6, 
p>0.05 
Non (38) 17.7 (2.1) 
Lower (39) 16.5 (2.0) 
Categoric search 
Errors 
Higher  (36) 16.7 (2.0) 
F (2,112)=0.1, 
p>0.05 
Non (38) 340.0 (9.6) 
Lower (39) 312.5 (9.2) 
Simple reaction time 
(ms) 
Higher  (36) 345.8 (9.3) 
F (2,112)=3.7, 
p<0.05 
Non (33) 86.9 (5.3) 
Lower (38) 86.6 (5.1) 
Verbal reasoning 
Number of trials 
Higher  (35) 93.3 (5.4) 
F (2,105)=0.5, 
p>0.05 
Non (33) 89.6 (1.4) 
Lower (38) 90.5 (1.4) 
Verbal reasoning 
% correct 
Higher  (35) 90.1 (1.5) 
F (2,105)=0.1, 
p>0.05 
Non (38) 4.0 (0.2) 
Lower (39) 4.1 (0.2) 
Repeated digits 
Hits/RT x100 
Higher  (36) 3.9 (0.2) 
F (2,112)=0.4, 
p>0.05 
Non (38) 19.5 (2.0) 
Lower (39) 21.5 (1.9) 
Repeated digits 
False alarms 
Higher  (36) 21.9 (1.9) 
F (2,112)=0.5, 
p>0.05 
Non (37) 110.3 (3.6) 
Lower (38) 111.6 (3.4) 
Semantic memory 
Number of trials 
Higher  (34) 109.6 (3.5) 
F (2,108)=0.1, 
p>0.05 
Non (37) 94.8 (0.5) 
Lower (38) 95.8 (0.5) 
Semantic memory 
% correct 
Higher  (34) 94.9 (0.5) 
F (2,108)=1.2, 
p>0.05 
Non (38) 33.0 (0.7) 
Lower (39) 32.6 (0.7) 
Recognition memory 
Number correct 
Higher  (36) 33.0 (0.7) 
F (2,112)=0.1, 
p>0.05 
Non (34) 820.7 (32.6) 
Lower (38) 865.7 (31.6) 
Recognition memory 
Mean RT (ms) 
Higher  (35) 896.9 (31.8) 
F (2,112)=1.2, 
p>0.05 
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Table 3. Age, personality scores and daily caffeine consumption for the different 
caffeine dose groups (means and s.e.s) 
 
Dose 
(mg/kg) 
Age Imp TA Caffeine/day 
(mg) 
0 22.7 (0.8) 4.5 (0.3) 39.6 (1.5) 60.7 (21.2) 
1 22.0 (0.5) 4.4 (0.2) 38.0 (1.0) 93.0 (15.2) 
2 20.6 (0.8) 4.3 (0.3) 41.0 (1.5) 87.4 (21.6) 
TA = trait anxiety. Imp = impulsivity 
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Table 4. Mean (s.e.) scores for mood and performance in the different caffeine dose 
conditions. Scores are adjusted means from ANCOVA. 
Variable Caffeine dose mg/kg (n) Mean (s.e.) 
Significance 
level 
0 (30) 243.3 (6.6) 
1 (60) 234.9 (4.7) 
Pre-session 
Alertness 
2 (30) 247.9 (6.6) 
F(2,119)=1.5 
p>0.05 
0 (30) 191.0 (4.2) 
1 (60) 185.6 (3.0) 
Pre-session 
Hedonic tone 
2 (30) 195.4 (4.2) 
F(2,119)=1.9 
p>0.05 
0 (30) 88.3 (2.3) 
1 (60) 85.1 (1.6) 
Pre-session 
Anxiety 
2 (30) 87.6 (2.3) 
F(2,119)=0.8 
p>0.05 
0 (30) 181.8 (4.5) 
1 (60) 183.3 (3.2) 
Post-session 
Hedonic tone 
2 (30) 189.0 (4.5) 
F(2,119)=0.7 
p>0.05 
0 (30) 90.0 (2.1) 
1 (60) 87.4 (1.5) 
Post-session 
Anxiety 
2 (30) 86.9 (2.1) 
F(2,119)=0.7 
p>0.05 
0 (29) 9.7 (0.5) 
1 (52) 9.7 (0.4) 
Free recall 
Number recalled 
2 (30) 9.4 (0.5) 
F(2,110)=0.2 
p>0.05 
0 (29) 0.8 (0.2) 
1 (52) 0.9 (0.1) 
Free recall 
Commission errors 
2 (30) 0.9 (0.2) 
F(2,110)=0.1 
p>0.05 
0 (30) 365.7 (4.3) 
1 (60) 362.9 (3.0) 
Focused attention 
Mean RT (ms) 
2 (30) 372.0 (4.3) 
F(2,119)=1.5 
p>0.05 
0 (30) 19.0 (2.6) 
1 (60) 15.0 (1.8) 
Focused attention 
Speed of encoding 
(ms) 2 (30) 14.2 (2.6) 
F(2,119)=1.1 
p>0.05 
0 (30) 0.6 (0.3) 
1 (60) 1.0 (0.2) 
Focused attention 
Long responses 
2 (30) 0.9 (0.3) 
F(2,119)=0.8 
p>0.05 
0 (30) 17.6 (1.4) 
1 (60) 17.5 (1.0) 
Focused attention 
Errors 
2 (30) 16.9 (1.4) 
F(2,119)=0.1 
p>0.05 
0 (30) 462.3 (5.7) 
1 (60) 470.5 (4.0) 
Categoric search 
Mean RT (ms) 
2 (30) 468.7 (5.7) 
F(2,119)=0.7 
p>0.05 
0 (30) 13.2 (2.6) 
1 (60) 10.9 (1.9) 
Categoric search 
Speed of encoding 
(ms) 2 (30) 9.2 (2.6) 
F(2,119)=0.6 
p>0.05 
0 (30) 11.1 (1.2) 
1 (60) 10.2 (0.8) 
Categoric search 
Long responses 
2 (30) 7.9 (1.2) 
F(2,119)=1.9 
p>0.05 
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0 (30) 16.3 (1.4) 
1 (60) 17.4 (1.0) 
Categoric search 
Errors 
2 (30) 16.6 (1.4) 
F(2,119)=0.3 
p>0.05 
0 (30) 328.2 (6.0) 
1 (60) 322.7 (4.3) 
Simple reaction time 
(ms) 
2 (30) 321.4 (6.0) 
F(2,119)=0.4 
p>0.05 
0 (29) 101.5 (4.5) 
1 (52) 100.2 (3.4) 
Verbal reasoning 
Number completed 
2 (30) 99.4 (4.5) 
F(2,110)=0.5 
p>0.05 
0 (29) 90.0 (1.0) 
1 (52) 91.5 (0.8) 
Verbal reasoning 
% correct 
2 (30) 92.7 (1.0) 
F(2,110)=1.9 
p>0.05 
0 (30) 17.8 (1.2) 
1 (60) 18.4 (0.9) 
Vigilance 
False alarms 
2 (30) 19.5 (1.2) 
F(2,119)=0.5 
p>0.05 
0 (29) 116.0 (1.2) 
1 (57) 117.5 (0.9) 
Semantic memory 
Number completed 
2 (30) 118.4 (1.2) 
F(2,115)=1.1 
p>0.05 
0 (29) 94.4 (0.5) 
1 (57) 94.3 (0.3) 
Semantic memory 
% correct 
2 (30) 93.6 (0.5) 
F(2,115)=1.0 
p>0.05 
0 (30) 30.2 (0.7) 
1 (60) 28.9 (0.5) 
Recognition memory 
Number correct 
2 (30) 30.0 (0.7) 
F(2,119)=1.8 
p>0.05 
0 (30) 899.5 (24.6) 
1 (60) 865.3 (17.4) 
Recognition memory 
Mean RT (ms) 
2 (30) 919.3 (24.5) 
F(2,119)=1.8 
p>0.05 
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Table 5. Interactions between dose of caffeine and regular consumption. 
 
Variable Consumer 0mg/kg 1mg/kg 2mg/kg Interaction 
Higher 234.4 (13.0) 237.8 (8.2) 249.3 (15.9) 
Lower 240.8 (11.4) 239.2 (9.8) 249.8 (11.8) Pre-session Alertness 
Non 255.7 (13.0) 229.6 (10.1) 246.2 (11.2) 
F(4,112)=0.5 
p>0.05 
Higher 194.7 (8.1) 187.7 (5.1) 199.6 (9.9) 
Lower 184.9 (7.0) 186.0 (6.1) 197.2 (7.3) 
Pre-session Hedonic 
tone 
Non 195.2 (8.1) 184.7 (6.3) 193.1 (7.0) 
F(4,112)=0.3 
p>0.05 
Higher 90.8 (4.3) 84.5 (2.7) 82.5 (5.2) 
Lower 86.2 (3.7) 87.8 (3.2) 87.7 (3.9) Pre-session Anxiety 
Non 88.3 (4.3) 84.2 (3.3) 90.2 (3.7) 
F(4,112)=0.7 
p>0.05 
Higher 181.1 (16.3) 217.5 (10.2) 239.2 (20.0) 
Lower 194.1 (14.2) 218.3 (12.2) 254.8 (14.8) Post-session alertness 
Non 200.1 (16.4) 224.2 (12.6) 234.9 (14.1) 
F(4,112)=0.4 
p>0.05 
Higher 182.2 (8.6) 182.7 (5.3) 185.9 (10.5) 
Lower 179.3 (7.4) 186.0 (6.4) 193.4 (7.7) 
Post-session Hedonic 
tone 
Non 183.2 (8.5) 184.5 (6.6) 186.7 (7.4) 
F(4,112)=0.2 
p>0.05 
Higher 92.4 (4.1) 86.5 (2.5) 82.0 (5.0) 
Lower 88.0 (3.5) 89.0 (3.0) 89.8 (3.7) Post-session Anxiety 
Non 91.2 (4.1) 88.6 (3.1) 87.8 (3.5) 
F(4,112)=0.6 
p>0.05 
Higher 10.0 (0.9) 9.9 (0.6) 10.8 (1.1) 
Lower 10.1 (0.8) 8.8 (0.7) 9.1 (0.8) 
Free recall 
Correct 
Non 9.0 (0.9) 10.2 (0.7) 9.0 (0.8) 
F(4,105)=1.1 
p>0.05 
Higher 0.8 (0.4) 1.0 (0.2) 1.4 (0.4) 
Lower 0.5 (0.3) 0.7 (0.3) 0.9 (0.3) 
Free recall 
Commission errors 
Non 1.2 (0.3) 0.8 (0.3) 0.6 (0.3) 
F(4,105)=0.9 
p>0.05 
Higher 367.3 (7.6) 365.8 (4.8) 366.4 (9.3) 
Lower 365.1 (6.6) 357.3 (5.7) 382.3 (6.9) 
Focused attention 
Mean RT (ms) 
Non 364.3 (7.6) 364.0 (5.9) 365.1 (6.6) 
F(4,112)=1.2 
p>0.05 
Higher 20.7 (4.8) 14.4 (3.0) 18.6 (5.7) 
Lower 20.4 (4.2) 21.3 (3.6) 12.3 (4.4) 
Focused attention 
Speed of encoding 
(ms) Non 16.2 (4.8) 12.1 (3.7) 11.6 (4.2) 
F(4,112)=0.7 
p>0.05 
Higher 0.9 (0.5) 1.0 (0.3) 1.4 (0.6) 
Lower 0.3 (0.4) 1.2 (0.3) 0.8 (0.4) 
Focused attention 
Long responses 
Non 0.6 (0.5) 1.0 (0.4) 0.9 (0.4) 
F(4,112)=0.4 
p>0.05 
Higher 18.9 (2.6) 17.1 (1.6) 18.2 (3.1) 
Lower 16.2 (2.2) 14.5 (1.9) 15.3 (2.3) 
Focused attention 
Errors 
Non 18.2 (2.6) 21.9 (2.0) 18.3 (2.2) 
F(4,112)=0.6 
p>0.05 
Higher 466.8 (10.2) 482.5 (6.4) 467.8 (12.5) 
Lower 455.0 (8.8) 468.9 (7.6) 470.3 (9.2) 
Categoric search 
Mean RT (ms) 
Non 467.2 (10.2) 459.3 (7.9) 467.1 (8.8) 
F(4,112)=0.8 
p>0.05 
Higher 20.0 (4.6) 12.4 (2.9) 2.9 (5.7) 
Lower 13.4 (4.0) 13.8 (3.5) 1.4 (4.2) 
Categoric search 
Speed of encoding 
(ms) Non 5.8 (4.7) 11.4 (3.6) 16.4 (4.0) 
F(4,112)=3.0 
p<0.05 
Higher 13.9 (2.2) 9.4 (1.4) 8.3 (2.7) 
Lower 11.3 (1.9) 11.4 (1.7) 7.2 (2.0) 
Categoric search 
Long responses 
Non 8.4 (2.2) 10.4 (1.7) 9.4 (1.9) 
F(4,112)=1.1 
p>0.05 
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Higher 14.3 (2.5) 16.2 (1.6) 19.2 (3.1) 
Lower 16.1 (2.2) 16.2 (1.9) 14.9 (2.3) 
Categoric search 
Errors 
Non 18.9 (2.5) 21.2 (2.0) 16.6 (2.2) 
F(4,112)=0.8 
p>0.05 
Higher 329.9 (11.1) 328.5 (6.8) 323.8 (13.4) 
Lower 319.8 (9.5) 309.9 (8.3) 306.1 (10.1) 
Simple reaction time 
(ms) 
Non 336.3 (10.9) 327.8 (8.5) 326.9 (9.5) 
F(4,112)=0.1 
p>0.05 
Higher 91.1 (8.8) 96.6 (5.8) 96.5 (10.2) 
Lower 115.2 (7.2) 102.1 (6.4) 98.9 (7.6) 
Verbal reasoning 
Number of trials 
Non 95.5 (8.3) 102.1 (6.7) 101.3 (7.2) 
F(4,105)=0.8 
p>0.05 
Higher 90.5 (1.8) 89.8 (1.2) 91.0 (2.1) 
Lower 87.8 (1.5) 90.5 (1..3) 93.7 (1.6) 
Verbal reasoning 
% correct 
Non 92.0 (1.7) 93.4 (1.4) 93.0 (1.5) 
F(4,105)=1.0 
p>0.05 
Higher 3.7 (0.2) 4.1 (0.2) 3.9 (0.2) 
Lower 4.3 (0.1) 4.4 (0.2) 4.4 (0.2) 
Vigilance 
Hits/RTx100 
Non 4.6 (0.3) 5.0 (0.2) 4.3 (0.2) 
F(4,112)=0.9 
p>0.05 
Higher 17.9 (2.3) 19.2 (2.0) 16.6 (2.3) 
Lower 19.3 (1.4) 17.4 (1.7) 18.7 (1.8) 
Vigilance 
False alarms 
Non 24.0 (2.8) 18.7 (2.1) 18.6 (2.0) 
F(4,112)=0.7 
p>0.05 
Higher 115.6 (2.2) 118.1 (1.4) 119.7 (2.7) 
Lower 115.4 (1.9) 116.9 (1.7) 115.8 (2.0) 
Semantic memory 
Number of trials 
Non 118.4 (2.3) 117.6 (1.8) 121.0 (1.9) 
F(4,108)=0.5 
p>0.05 
Higher 94.6 (0.9) 94.4 (0.6) 93.4 (1.1) 
Lower 93.8 (0.7) 94.8 (07) 94.6 (0.8) 
Semantic memory 
% correct 
Non 95.3 (0.9) 94.0 (0.7) 92.9 (0.7) 
F(4,108)=1.1 
p>0.05 
Higher 29.7 (1.3) 28.1 (0.8) 29.1 (1.5) 
Lower 29.6 (1.1) 28.8 (0.9) 19.7 (1.1) 
Recognition memory 
Number correct 
Non 31.5 (1.2) 29.8 (1.0) 30.9 (1.1) 
F(4,112)=0.1 
p>0.05 
Higher 871.4 (49.4) 849.9 (31.4) 938.6 (56.9) 
Lower 959.2 (40.2) 860.5 (36.1) 893.9 (42.1) 
Recognition memory 
Mean RT (ms) 
Non 855.2 (46.5) 896.2 (37.2) 926.3 (42.5) 
F(4,106)=1.1 
p>0.05 
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Table 6: Effects of caffeine on alertness and repeated digits vigilance RT for 
volunteers who had abstained from caffeine for > 6 hours and < 6 hours (scores are 
the adjusted means, s.e.s in parentheses)  
 
 
 Caffeine 
(abstained > 6hr) 
Caffeine 
( < 6 hr) 
Placebo 
( > 6hr) 
 
Placebo 
( < 6hr) 
Variable     
Alertness 
(high scores = 
greater 
alertness)  
261.4 (13.4) 253.1 (6.5)  227.7 (11.9) 239.6 (6.7) 
     
Repeated digits 
RT (ms) 
671 (17) 666 (9) 691 (17) 692 (9) 
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Figure 1. Post-task mood: Mean alertness scores in the caffeine conditions. Higher 
score = greater alertness. Scores are adjusted from ANCOVA and s.e. are shown as 
error bars. 
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Figure 2. Vigilance task: Mean performance scores in the caffeine conditions. Higher 
scores = better performance. Scores are adjusted means from the ANCOVA and s.e.s 
are shown as error bars. 
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